Table 3.
Ingenuity pathway analysis of anoctamin 5-depleted NUGC4 cells
|
Category
|
Name
|
Molecules
|
P
value (range)
|
| Disease and Disorders | Cancer | 3136 | 1.54 × 10-3–2.23 × 10-15 |
| Neurological Disease | 76 | 1.27 × 10-3–2.23 × 10-15 | |
| Organismal Injury and Abnormalities | 3147 | 1.54 × 10-3–2.23 × 10-15 | |
| Cardiovascular Disease | 138 | 1.43 × 10-3–4.07 × 10-14 | |
| Reproductive System Disease | 1942 | 1.54 × 10-3–1.09 × 10-10 | |
| Molecular and Cellular Functions | DNA Replication, Recombination, and Repair | 460 | 1.54 × 10-3–9.69 × 10-22 |
| Cell Cycle | 650 | 1.54 × 10-3–1.98 × 10-20 | |
| Cellular Assembly and Organization | 533 | 1.57 × 10-3–9.22 × 10-16 | |
| Cellular Development | 691 | 1.59 × 10-3–2.66 × 10-14 | |
| Cellular Growth and Proliferation | 677 | 1.40 × 10-3–2.66 × 10-14 | |
| Physiological System Development and Function | Connective Tissue Development and Function | 60 | 1.14 × 10-3–8.83 × 10-6 |
| Tissue Development | 164 | 1.57 × 10-3–1.11 × 10-4 | |
| Embryonic Development | 80 | 1.21 × 10-3–2.07 × 10-4 | |
| Hair and Skin Development and Function | 55 | 6.37 × 10-4–2.07 × 10-4 | |
| Organ Development | 69 | 6.37 × 10-4–2.07 × 10-4 |